Eli Lilly expands manufacturing for popular drugs Zepbound and Mounjaro
Eli Lilly to invest $5 billion in Indiana site to increase production of popular weight-loss and diabetes treatments, Zepbound and Mounjaro.
Tirzepatide News & Breaking Stories
Eli Lilly Launches Open Letter about Mounjaro® and Zepbound® Use
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.
Walmart stock split, Jim Cramer chipmaker next
Jim Cramer discusses Walmart's stock split, Berkshire Hathaway's underperformance, Domino's strong results, and Zealand Pharma's promising drug trial.
U.S. FDA Approves New Version of Diabetes Drug Mounjaro for Weight Loss
New diabetes drug Zepbound, also known as tirzepatide, can be sold as a weight-loss drug, helping dieters lose 40-60 pounds.
Get Weekly News Updates
Subscribe to SHUT Newsletter and be up to date with the current events. Be informed, don't settle for fake news.